Yoshiyuki Furumatsu a, b , Yasuyuki Nagasawa a , Tatsuya Shoji b , Ryohei Yamamoto a , Kenichiro Iio a , Isao Matsui a , Yoshitsugu Takabatake a , Jun-ya Kaimori a , Hirotsugu Iwatani a , Tetsuya Kaneko b , Yoshiharu Tsubakihara b , Enyu Imai a , Yoshitaka Isaka a , Hiromi Rakugi a
12 August 2010
Background: Type IV collagen is one of the major components of basement membrane. In diabetic nephropathy, it is already known that urinary excretion of type IV collagen increases with the disease progression. However, in nondiabetic kidney disease, urinary type IV collagen (u-IVc) levels have not been extensively investigated. The aim of this study was to evaluate u-IVc levels in various nephropathies except diabetic nephropathy. Methods: u-IVc levels were measured cross-sectionally from 527 biopsy-proven nondiabetic renal disease patients at tertiary care hospitals by one-step sandwich enzyme immunoassay. Results: On simple regression analyses, u-IVc levels had positive correlation with age, blood pressure, urinary protein (u-Prot), urinary β<sub>2</sub> microglobulin, urinary N-acetyl-β- D-glucosaminidase, HbA<sub>1</sub>c, and selectivity index (SI), while u-IVc had negative correlation with eGFR and serum albumin. Multiple regression analyses revealed that u-IVc was positively correlated with u-Prot, HbA<sub>1</sub>c and SI. Among biopsy-proven nondiabetic nephropathies, elevation of u-IVc was distinctively observed in membranous nephropathy and anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis. Conclusion: u-IVc levels were elevated with the increase in u-Prot, HbA<sub>1</sub>c and SI. In addition, among nondiabetic kidney disease, elevation of u-IVc was observed in patients with membranous nephropathy and ANCA, which might reflect the thickening of basement membrane or severe kidney damage.